Michael C. Badia

622 total citations
8 papers, 333 citations indexed

About

Michael C. Badia is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Michael C. Badia has authored 8 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Surgery. Recurrent topics in Michael C. Badia's work include Plant biochemistry and biosynthesis (3 papers), Chemical Synthesis and Analysis (2 papers) and Organophosphorus compounds synthesis (2 papers). Michael C. Badia is often cited by papers focused on Plant biochemistry and biosynthesis (3 papers), Chemical Synthesis and Analysis (2 papers) and Organophosphorus compounds synthesis (2 papers). Michael C. Badia collaborates with scholars based in United States, Germany and Malaysia. Michael C. Badia's co-authors include Donald S. Karanewsky, Melanie J. Loots, Edward W. Petrillo, David W. Cushman, Tamara Dejneka, Jack M. DeForrest, J.R. Powell, Trudy H. Grossman, Anne‐Laure Grillot and Yunyi Wei and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Michael C. Badia

8 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael C. Badia United States 7 222 148 45 33 23 8 333
Fuk‐Wah Sum United States 11 214 1.0× 271 1.8× 25 0.6× 26 0.8× 28 1.2× 13 485
Anthony K. L. Fung United States 13 273 1.2× 201 1.4× 30 0.7× 18 0.5× 33 1.4× 20 456
Laurent Gavara France 14 181 0.8× 237 1.6× 21 0.5× 41 1.2× 42 1.8× 32 453
Tuan P. Tran United States 11 176 0.8× 183 1.2× 25 0.6× 42 1.3× 12 0.5× 14 337
Jo Alen Belgium 11 144 0.6× 118 0.8× 21 0.5× 46 1.4× 40 1.7× 17 395
Peter H. Milner United States 10 160 0.7× 251 1.7× 16 0.4× 19 0.6× 16 0.7× 26 435
Laurent Gomez United States 13 239 1.1× 284 1.9× 27 0.6× 26 0.8× 12 0.5× 26 459
Brett D. Allison United States 9 115 0.5× 248 1.7× 31 0.7× 21 0.6× 20 0.9× 15 344
Yoichi Hiyama Japan 5 129 0.6× 247 1.7× 31 0.7× 19 0.6× 8 0.3× 10 362
Pascal Coudert France 13 151 0.7× 359 2.4× 23 0.5× 18 0.5× 11 0.5× 54 505

Countries citing papers authored by Michael C. Badia

Since Specialization
Citations

This map shows the geographic impact of Michael C. Badia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Badia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Badia more than expected).

Fields of papers citing papers by Michael C. Badia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Badia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Badia. The network helps show where Michael C. Badia may publish in the future.

Co-authorship network of co-authors of Michael C. Badia

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Badia. A scholar is included among the top collaborators of Michael C. Badia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Badia. Michael C. Badia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Badia, Michael C., S.F. Bellon, Anne‐Laure Grillot, et al.. (2010). Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase. Bioorganic & Medicinal Chemistry Letters. 20(9). 2828–2831. 85 indexed citations
2.
Armistead, David M., Michael C. Badia, David D. Deininger, et al.. (1995). Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506. Acta Crystallographica Section D Biological Crystallography. 51(4). 522–528. 52 indexed citations
3.
Karanewsky, Donald S. & Michael C. Badia. (1993). Phosphorus-containing inhibitors of HMG-CoA Reductase. 3. Synthesis of hydroxyphosphinyl-analogues of the mevinic acids. Tetrahedron Letters. 34(1). 39–42. 5 indexed citations
4.
5.
Karanewsky, Donald S., Michael C. Badia, Carl P. Ciosek, et al.. (1990). Phosphorus-containing inhibitors of HMG-CoA reductase. I. 4-[(2-Arylethyl)hydroxyphosphinyl]-3-hydroxybutanoic acids: a new class of cell selective inhibitors of cholesterol biosynthesis. Journal of Medicinal Chemistry. 33(11). 2952–2956. 42 indexed citations
6.
Karanewsky, Donald S., Michael C. Badia, David W. Cushman, et al.. (1990). (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogs of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline. Journal of Medicinal Chemistry. 33(5). 1459–1469. 18 indexed citations
7.
Karanewsky, Donald S., Michael C. Badia, David W. Cushman, et al.. (1988). (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline, a novel orally active inhibitor of ACE. Journal of Medicinal Chemistry. 31(1). 204–212. 82 indexed citations
8.
Karanewsky, Donald S. & Michael C. Badia. (1986). Synthesis of phosphonic monoesters from phosphonous acids. Tetrahedron Letters. 27(16). 1751–1754. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuk‐Wah Sum Breakdown of academic impact, for papers by Anthony K. L. Fung Breakdown of academic impact, for papers by Laurent Gavara Breakdown of academic impact, for papers by Tuan P. Tran Breakdown of academic impact, for papers by Jo Alen Breakdown of academic impact, for papers by Peter H. Milner Breakdown of academic impact, for papers by Laurent Gomez Breakdown of academic impact, for papers by Brett D. Allison Breakdown of academic impact, for papers by Yoichi Hiyama Breakdown of academic impact, for papers by Pascal Coudert
Rankless by CCL
2026